Indu Raman
Impact in
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
-
- T-cell and B-cell Immunology
- Atherosclerosis and Cardiovascular Diseases
- Immune Cell Function and Interaction
Papers in
-
- Mast cells and histamine 2
- Atherosclerosis and Cardiovascular Diseases 2
- Co-authors
- Quan‐Zhen Li (11 shared papers)Hui Luo (1 shared paper)Honglin Zhu (1 shared paper)Tao Chen (1 shared paper)Wentao Mi (1 shared paper)Xiaoxia Zuo (1 shared paper)Shengxi Liu (1 shared paper)Mei Yan (3 shared papers)
- Journals
- Clinical Gastroenterology and Hepatology (2 papers)Blood (2 papers)Pediatric Rheumatology (1 paper)Journal of Leukocyte Biology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Indu Raman
17 papers receiving 278 citations
Peers
Comparison fields: 5 of 51
- Rheumatology 114
- Immunology 117
- Hepatology 35
- Genetics 37
- Cancer Research 31
Countries citing papers authored by Indu Raman
This map shows the geographic impact of Indu Raman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indu Raman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indu Raman more than expected).
Fields of papers citing papers by Indu Raman
This network shows the impact of papers produced by Indu Raman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indu Raman. The network helps show where Indu Raman may publish in the future.
Co-authors
The 25 scholars most cited alongside Indu Raman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 108 | |
| 2 | 2014 | 31 | |
| 3 | 2016 | 28 | |
| 4 | 2013 | 25 | |
| 5 | 2020 | 19 | |
| 6 | 2019 | 16 | |
| 7 | 2012 | 13 | |
| 8 | 2015 | 10 | |
| 9 | 2019 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 4 | |
| 13 | 2013 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 |
About Indu Raman
Indu Raman is a scholar working on Immunology, Molecular Biology, Genetics, Epidemiology and Rheumatology, having authored 18 papers that have together received 281 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Systemic Lupus Erythematosus Research (3 papers), Mast cells and histamine (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Salivary Gland Disorders and Functions (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and Ocular Surface and Contact Lens (2 papers). The work is most often cited by research in Rheumatology (114 citations), Immunology (117 citations), Hepatology (35 citations), Genetics (37 citations) and Cancer Research (31 citations). Indu Raman has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Quan‐Zhen Li, Hui Luo, Honglin Zhu, Tao Chen, Wentao Mi, Xiaoxia Zuo, Shengxi Liu, Mei Yan, Yajuan Li and Yong Du. Their work appears in journals such as Clinical Gastroenterology and Hepatology, Blood, Pediatric Rheumatology, Journal of Leukocyte Biology and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.